This Biotech Clubhouse Session will cover insights into best practices for providing access to medicines in the developing from industry experts exploring learnings from Gilead Science’s HIV and Hepatitis C Access to Medicines Program. We take lessons from past efforts, look at the current COVID response, and discuss a path forward for low and middle-income countries’ access to COVID vaccines, as well as future life-saving medicines. Guests: Clifford Samuel, Claudio Lilienfeld, Kash Rangan. Host: Chris Garabedian.  Full auto-generated transcript: click here Originally aired on June 7th, 2021 on Biotech Clubhouse. Shared with permission

This Biotech Clubhouse Session will cover insights into best practices for providing access to medicines in the developing from industry experts exploring learnings from Gilead Science’s HIV and Hepatitis C Access to Medicines Program. We take lessons from past efforts, look at the current COVID response, and discuss a path forward for low and middle-income countries’ access to COVID vaccines, as well as future life-saving medicines. Guests: Clifford Samuel, Claudio Lilienfeld, Kash Rangan. Host: Chris Garabedian.  Full auto-generated transcript: <a href="https://drive.google.com/file/d/1HM-tS2xbZ3gQOtOm33LXaTZs1eaVrIuE/view?usp=sharing" rel="nofollow" target="_blank">click here</a> Originally aired on June 7th, 2021 on Biotech Clubhouse. Shared with permission

Global Access Strategies: COVID Vaccines and Other Meds

Afdhel Aziz

Companies can change the world for the better while advancing their own business goals by supporting community-building activities. Featuring Life Science Cares (LSC) Impact Breakfast Keynote Speaker, Afdhel Aziz, and hosted by LSC founder, Rob Perez.  Originally aired May 27th on Biotech Clubhouse. Click here for transcript (autogenerated)

Companies can change the world for the better while advancing their own business goals by supporting community-building activities. Featuring Life Science Cares (LSC) Impact Breakfast Keynote Speaker, Afdhel Aziz, and hosted by LSC founder, Rob Perez. Originally aired May 27th on Biotech Clubhouse. Click here for <a href="https://drive.google.com/file/d/1U-pkpnEsYhu9yziFiWtDeHDFh50jF7v6/view?usp=sharing" rel="nofollow" target="_blank">transcript</a> (autogenerated)

Good is the New Cool with Afdhel Aziz

A cross-disciplinary group of oncology experts and a top wall street biotech analyst discuss the most promising new therapies presenting data at ASCO. Featuring Sally Church, James Gulley, Aleksandra Filipovic, and Umer Raffat. Moderated by Daphne Zohar. Originally aired May 21st on Biotech Clubhouse. Click for transcript

A cross-disciplinary group of oncology experts and a top wall street biotech analyst discuss the most promising new therapies presenting data at ASCO. Featuring Sally Church, James Gulley, Aleksandra Filipovic, and Umer Raffat. Moderated by Daphne Zohar. Originally aired May 21st on Biotech Clubhouse. <a href="https://otter.ai/u/-nqbKFxKLeZacMkhvMfoK4GFJvo" rel="nofollow" target="_blank">Click for transcript</a>

Pre-ASCO Discussion: Perspectives on Emerging Oncology Treatments

Biotech Clubhouse

The Best Multi-Part Documentaries, with documentaries on Obama, Federer vs Nadal, the making of Star Wars, Netflix vs Blockbuster and more. Add episodes you're interested into your queue below!

Best Multi-Part Documentaries

The best podcast episodes on Startups. For anyone working in a startup, or anyone interested in the incredible stories behind how people built companies like Instagram, and Facebook. Offering both practical advice and insights, as well as the stories for how many of the biggest startups got to where they are today. Add episodes you're interested into your queue below!